MrK88088 personal page - To The Moon

MrK88088

MrK88088

No personal profile

15Follow

2Followers

0Topic

0Badge

05-26

This stock will be hyper after split.... Thx to fomo... And the institutional buyers will join the party too this will lead to higher stock price eventually..until the next earnings....

Nvidia Just Announced a Stock Split. Time to Buy?

07-24

Hope the democrats win this election, policy will not be too far away from Biden's. Trade for a year or 2 for the clean energy and EVs to climb back up.

2021-05-05

QDEL should be an insurance stock in your portfolio. Although vaccination is widely propagated but the mutation is ever changing. Buy QDEL to hedge your portfolio. As long as the virus is still around the world.

Quidel (QDEL) to Report Q1 Earnings: What's in the Offing?

2021-04-28

Covid-19 will be around for quite a while. Testing still remains essential even after vaccination drive.

Quidel Corporation (NASDAQ:QDEL) Analysts Just Cut Their EPS Forecasts Substantially

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3552211490267635","uuid":"3552211490267635","gmtCreate":1589118455382,"gmtModify":1712580949290,"name":"MrK88088","pinyin":"mrk88088","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/177889ab348d52aa048bc5d523f30868","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":15,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.54%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.55%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":7,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":331050407366704,"gmtCreate":1721830912509,"gmtModify":1721831259832,"author":{"id":"3552211490267635","authorId":"3552211490267635","name":"MrK88088","avatar":"https://community-static.tradeup.com/news/177889ab348d52aa048bc5d523f30868","crmLevel":7,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3552211490267635","authorIdStr":"3552211490267635"},"themes":[],"htmlText":"Hope the democrats win this election, policy will not be too far away from Biden's. Trade for a year or 2 for the clean energy and EVs to climb back up.","listText":"Hope the democrats win this election, policy will not be too far away from Biden's. Trade for a year or 2 for the clean energy and EVs to climb back up.","text":"Hope the democrats win this election, policy will not be too far away from Biden's. Trade for a year or 2 for the clean energy and EVs to climb back up.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331050407366704","isVote":1,"tweetType":1,"viewCount":372,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":310105200161048,"gmtCreate":1716713950207,"gmtModify":1716713954187,"author":{"id":"3552211490267635","authorId":"3552211490267635","name":"MrK88088","avatar":"https://community-static.tradeup.com/news/177889ab348d52aa048bc5d523f30868","crmLevel":7,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3552211490267635","authorIdStr":"3552211490267635"},"themes":[],"htmlText":"This stock will be hyper&nbsp;after split.... Thx to fomo... And the institutional buyers&nbsp;will&nbsp;join the party&nbsp;too this will lead to higher stock price eventually..until the next earnings....&nbsp;","listText":"This stock will be hyper&nbsp;after split.... Thx to fomo... And the institutional buyers&nbsp;will&nbsp;join the party&nbsp;too this will lead to higher stock price eventually..until the next earnings....&nbsp;","text":"This stock will be hyper after split.... Thx to fomo... And the institutional buyers will join the party too this will lead to higher stock price eventually..until the next earnings....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/310105200161048","repostId":"2438865218","repostType":2,"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":102877126,"gmtCreate":1620201507165,"gmtModify":1704340110395,"author":{"id":"3552211490267635","authorId":"3552211490267635","name":"MrK88088","avatar":"https://community-static.tradeup.com/news/177889ab348d52aa048bc5d523f30868","crmLevel":7,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3552211490267635","authorIdStr":"3552211490267635"},"themes":[],"htmlText":"QDEL should be&nbsp;an insurance stock in your portfolio. Although vaccination is widely propagated but the mutation is ever changing. Buy QDEL to hedge your portfolio. As long as the virus is still around the world.&nbsp;","listText":"QDEL should be&nbsp;an insurance stock in your portfolio. Although vaccination is widely propagated but the mutation is ever changing. Buy QDEL to hedge your portfolio. As long as the virus is still around the world.&nbsp;","text":"QDEL should be an insurance stock in your portfolio. Although vaccination is widely propagated but the mutation is ever changing. Buy QDEL to hedge your portfolio. As long as the virus is still around the world.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102877126","repostId":"2133431805","repostType":2,"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377489453,"gmtCreate":1619553237472,"gmtModify":1704725757085,"author":{"id":"3552211490267635","authorId":"3552211490267635","name":"MrK88088","avatar":"https://community-static.tradeup.com/news/177889ab348d52aa048bc5d523f30868","crmLevel":7,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3552211490267635","authorIdStr":"3552211490267635"},"themes":[],"htmlText":"Covid-19 will be around for quite a while. Testing still remains essential even after vaccination drive.&nbsp;","listText":"Covid-19 will be around for quite a while. Testing still remains essential even after vaccination drive.&nbsp;","text":"Covid-19 will be around for quite a while. Testing still remains essential even after vaccination drive.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/377489453","repostId":"2129649863","repostType":2,"isVote":1,"tweetType":1,"viewCount":341,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":310105200161048,"gmtCreate":1716713950207,"gmtModify":1716713954187,"author":{"id":"3552211490267635","authorId":"3552211490267635","name":"MrK88088","avatar":"https://community-static.tradeup.com/news/177889ab348d52aa048bc5d523f30868","crmLevel":7,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3552211490267635","authorIdStr":"3552211490267635"},"themes":[],"htmlText":"This stock will be hyper&nbsp;after split.... Thx to fomo... And the institutional buyers&nbsp;will&nbsp;join the party&nbsp;too this will lead to higher stock price eventually..until the next earnings....&nbsp;","listText":"This stock will be hyper&nbsp;after split.... Thx to fomo... And the institutional buyers&nbsp;will&nbsp;join the party&nbsp;too this will lead to higher stock price eventually..until the next earnings....&nbsp;","text":"This stock will be hyper after split.... Thx to fomo... And the institutional buyers will join the party too this will lead to higher stock price eventually..until the next earnings....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/310105200161048","repostId":"2438865218","repostType":2,"repost":{"id":"2438865218","pubTimestamp":1716692400,"share":"https://ttm.financial/m/news/2438865218?lang=&edition=fundamental","pubTime":"2024-05-26 11:00","market":"us","language":"en","title":"Nvidia Just Announced a Stock Split. Time to Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2438865218","media":"Motley Fool","summary":"Nvidia's maneuver will lower the price of each individual share.","content":"<html><head></head><body><ul style=\"\"><li><p>Nvidia stock has soared to over $1,000 per share after the company announced record revenue in its latest earnings report.</p></li><li><p>The company is benefiting from demand for its artificial intelligence (AI) products and services.</p></li></ul><p>For the past several months, investors have been wondering if <strong>Nvidia</strong> would launch a stock split. That&#39;s after the technology giant&#39;s stock soared in recent years, reaching nearly $1,000. And it actually did reach $1,000 this week in the trading session following Nvidia&#39;s earnings report and announcement of a stock split. After the split, the chip designer&#39;s shares will be trading at a much lower level.</p><p>But this move won&#39;t change Nvidia&#39;s $2.3 trillion market value. Instead, a stock split involves issuing more shares to current shareholders and this will result in more shares trading at a lower price; current shareholders will end up with the same dollar value of stock as they had before the split. The drop in price will make the stock accessible to a broader range of investors, and Nvidia even said as part of its announcement that this was its motivation for making the move.</p><p>So, today, as Nvidia takes the step many investors were waiting for, is it time to buy the shares?</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/38a7e1b8ca735a7419832274762c3588\" alt=\"Image source: Getty Images.\" title=\"Image source: Getty Images.\" tg-width=\"700\" tg-height=\"466\"/><span>Image source: Getty Images.</span></p><h2 id=\"id_1622230468\">Why are investors interested in stock splits?</h2><p>It&#39;s important to note that it&#39;s not a good idea to buy a stock just because the company launched a split -- it&#39;s simply a mechanical operation. A stock split itself won&#39;t push a stock&#39;s value higher or lower. So now you might ask, if that&#39;s the case, why are investors so interested in whether a company will split its stock?</p><p>In many cases, the move suggests a company is optimistic about its future and believes that its shares have what it takes to take off once again. Generally, the company has performed well from an earnings perspective in recent years, and this has prompted the stock price gains we&#39;ve already seen. Now, by splitting its shares, a company is implying that those gains aren&#39;t over, and from the stock&#39;s lower price it once again may soar and even eventually return to its pre-split level.</p><p>Now let&#39;s consider the Nvidia operation, a 10-for-1 stock split, effective June 7. This means that if you hold one Nvidia share today, post-split you&#39;ll own 10, but the value of your holding will remain the same. And if you buy shares of Nvidia after the split, if they&#39;re still trading at $1,000 before the split, they&#39;d drop to $100 per share after the split.</p><p>This maneuver will make it easier for investors who don&#39;t have access to fractional shares or those who prefer buying full shares to invest. And the $1,000 mark represents a psychological barrier for some investors, who would automatically hesitate to buy even if valuation is reasonable. Nvidia&#39;s stock split will remove this roadblock and pave the way for them to get in on this tech giant.</p><h2 id=\"id_52790925\">Nvidia&#39;s five stock splits</h2><p>Nvidia is no stranger to stock splits, having completed five in the past 24 years. And each time Nvidia announced a split, the stock price was considerably lower than it is today, so I&#39;m not too surprised that Nvidia decided on this move right now.</p><p>Let&#39;s get back to our question: Is it time to buy the shares? It is -- but not because of Nvidia&#39;s upcoming stock split. Nvidia&#39;s shares have climbed after its past stock splits, but this movement is due to the company&#39;s increasing revenue and demand for its products.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/c1429fe86800588de0fc86fde2cf4124\" alt=\"NVDA data by YCharts\" title=\"NVDA data by YCharts\" tg-width=\"720\" tg-height=\"456\"/><span>NVDA data by YCharts</span></p><p>And a look at Nvidia&#39;s recent earnings report and the general AI market offer us reason to be optimistic about the future. The company reported triple-digit growth in revenue and net income in the fiscal 2025 first quarter, with revenue reaching record levels. At the same time, gross margin is on the rise, widening to more than 78%, so Nvidia is becoming more and more profitable.</p><p>The company says demand for its products and services is surpassing supply, and as Nvidia prepares to launch its new Blackwell architecture and most powerful chip ever, it&#39;s easy to imagine demand remaining strong. Especially considering AI market forecasts. Analysts predict the market will reach more than $1 trillion by the end of the decade. All of this supports the idea of more growth ahead for Nvidia.</p><p>Meanwhile, Nvidia shares trade for about 34 times forward earnings estimates, which looks very reasonable considering long-term prospects. That makes Nvidia a buy -- whether you make the move before or after the stock split.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Just Announced a Stock Split. Time to Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Just Announced a Stock Split. Time to Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-26 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2024/05/25/nvidia-just-announced-a-stock-split-time-to-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nvidia stock has soared to over $1,000 per share after the company announced record revenue in its latest earnings report.The company is benefiting from demand for its artificial intelligence (AI) ...</p>\n\n<a href=\"https://www.fool.com/investing/2024/05/25/nvidia-just-announced-a-stock-split-time-to-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4527":"明星科技股","BK4543":"AI","LU0061474960.USD":"天利环球焦点基金AU Acc","LU0061474705.USD":"THREADNEEDLE (LUX) GLOBAL DYNAMIC REAL RETURN \"AU\" (USD) ACC","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","LU0276348264.USD":"THREADNEEDLE (LUX) GLOBAL DYNAMIC REAL RETURN\"AUP\" (USD) INC","LU0079474960.USD":"联博美国增长基金A","IE00BFSS8Q28.SGD":"Janus Henderson Balanced A Inc SGD-H","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","BK4581":"高盛持仓","BK4549":"软银资本持仓","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","IE0009356076.USD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A2\" (USD) ACC","BK4548":"巴美列捷福持仓","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","IE00BFSS7M15.SGD":"Janus Henderson Balanced A Acc SGD-H","IE00BJJMRX11.SGD":"Janus Henderson Balanced A Acc SGD","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU0238689110.USD":"贝莱德环球动力股票基金","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU0072462426.USD":"贝莱德全球配置 A2","BK4554":"元宇宙及AR概念","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4592":"伊斯兰概念","BK4532":"文艺复兴科技持仓","LU0082616367.USD":"摩根大通美国科技A（dist）","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","LU0080751232.USD":"富达环球多元动力基金A","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0308772762.SGD":"Blackrock Global Allocation A2 SGD-H","IE00BKDWB100.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5H\" (SGDHDG) ACC","IE00BMPRXR70.SGD":"Neuberger Berman 5G Connectivity A Acc SGD-H","LU0234572021.USD":"高盛美国核心股票组合Acc","IE00B7KXQ091.USD":"Janus Henderson Balanced A Inc USD","LU0353189763.USD":"ALLSPRING  US ALL CAP GROWTH FUND \"I\" (USD) ACC"},"source_url":"https://www.fool.com/investing/2024/05/25/nvidia-just-announced-a-stock-split-time-to-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2438865218","content_text":"Nvidia stock has soared to over $1,000 per share after the company announced record revenue in its latest earnings report.The company is benefiting from demand for its artificial intelligence (AI) products and services.For the past several months, investors have been wondering if Nvidia would launch a stock split. That's after the technology giant's stock soared in recent years, reaching nearly $1,000. And it actually did reach $1,000 this week in the trading session following Nvidia's earnings report and announcement of a stock split. After the split, the chip designer's shares will be trading at a much lower level.But this move won't change Nvidia's $2.3 trillion market value. Instead, a stock split involves issuing more shares to current shareholders and this will result in more shares trading at a lower price; current shareholders will end up with the same dollar value of stock as they had before the split. The drop in price will make the stock accessible to a broader range of investors, and Nvidia even said as part of its announcement that this was its motivation for making the move.So, today, as Nvidia takes the step many investors were waiting for, is it time to buy the shares?Image source: Getty Images.Why are investors interested in stock splits?It's important to note that it's not a good idea to buy a stock just because the company launched a split -- it's simply a mechanical operation. A stock split itself won't push a stock's value higher or lower. So now you might ask, if that's the case, why are investors so interested in whether a company will split its stock?In many cases, the move suggests a company is optimistic about its future and believes that its shares have what it takes to take off once again. Generally, the company has performed well from an earnings perspective in recent years, and this has prompted the stock price gains we've already seen. Now, by splitting its shares, a company is implying that those gains aren't over, and from the stock's lower price it once again may soar and even eventually return to its pre-split level.Now let's consider the Nvidia operation, a 10-for-1 stock split, effective June 7. This means that if you hold one Nvidia share today, post-split you'll own 10, but the value of your holding will remain the same. And if you buy shares of Nvidia after the split, if they're still trading at $1,000 before the split, they'd drop to $100 per share after the split.This maneuver will make it easier for investors who don't have access to fractional shares or those who prefer buying full shares to invest. And the $1,000 mark represents a psychological barrier for some investors, who would automatically hesitate to buy even if valuation is reasonable. Nvidia's stock split will remove this roadblock and pave the way for them to get in on this tech giant.Nvidia's five stock splitsNvidia is no stranger to stock splits, having completed five in the past 24 years. And each time Nvidia announced a split, the stock price was considerably lower than it is today, so I'm not too surprised that Nvidia decided on this move right now.Let's get back to our question: Is it time to buy the shares? It is -- but not because of Nvidia's upcoming stock split. Nvidia's shares have climbed after its past stock splits, but this movement is due to the company's increasing revenue and demand for its products.NVDA data by YChartsAnd a look at Nvidia's recent earnings report and the general AI market offer us reason to be optimistic about the future. The company reported triple-digit growth in revenue and net income in the fiscal 2025 first quarter, with revenue reaching record levels. At the same time, gross margin is on the rise, widening to more than 78%, so Nvidia is becoming more and more profitable.The company says demand for its products and services is surpassing supply, and as Nvidia prepares to launch its new Blackwell architecture and most powerful chip ever, it's easy to imagine demand remaining strong. Especially considering AI market forecasts. Analysts predict the market will reach more than $1 trillion by the end of the decade. All of this supports the idea of more growth ahead for Nvidia.Meanwhile, Nvidia shares trade for about 34 times forward earnings estimates, which looks very reasonable considering long-term prospects. That makes Nvidia a buy -- whether you make the move before or after the stock split.","news_type":1},"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":331050407366704,"gmtCreate":1721830912509,"gmtModify":1721831259832,"author":{"id":"3552211490267635","authorId":"3552211490267635","name":"MrK88088","avatar":"https://community-static.tradeup.com/news/177889ab348d52aa048bc5d523f30868","crmLevel":7,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3552211490267635","authorIdStr":"3552211490267635"},"themes":[],"htmlText":"Hope the democrats win this election, policy will not be too far away from Biden's. Trade for a year or 2 for the clean energy and EVs to climb back up.","listText":"Hope the democrats win this election, policy will not be too far away from Biden's. Trade for a year or 2 for the clean energy and EVs to climb back up.","text":"Hope the democrats win this election, policy will not be too far away from Biden's. Trade for a year or 2 for the clean energy and EVs to climb back up.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331050407366704","isVote":1,"tweetType":1,"viewCount":372,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":102877126,"gmtCreate":1620201507165,"gmtModify":1704340110395,"author":{"id":"3552211490267635","authorId":"3552211490267635","name":"MrK88088","avatar":"https://community-static.tradeup.com/news/177889ab348d52aa048bc5d523f30868","crmLevel":7,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3552211490267635","authorIdStr":"3552211490267635"},"themes":[],"htmlText":"QDEL should be&nbsp;an insurance stock in your portfolio. Although vaccination is widely propagated but the mutation is ever changing. Buy QDEL to hedge your portfolio. As long as the virus is still around the world.&nbsp;","listText":"QDEL should be&nbsp;an insurance stock in your portfolio. Although vaccination is widely propagated but the mutation is ever changing. Buy QDEL to hedge your portfolio. As long as the virus is still around the world.&nbsp;","text":"QDEL should be an insurance stock in your portfolio. Although vaccination is widely propagated but the mutation is ever changing. Buy QDEL to hedge your portfolio. As long as the virus is still around the world.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102877126","repostId":"2133431805","repostType":2,"repost":{"id":"2133431805","pubTimestamp":1620146824,"share":"https://ttm.financial/m/news/2133431805?lang=&edition=fundamental","pubTime":"2021-05-05 00:47","market":"us","language":"en","title":"Quidel (QDEL) to Report Q1 Earnings: What's in the Offing?","url":"https://stock-news.laohu8.com/highlight/detail?id=2133431805","media":"Zacks","summary":"Quidel Corporation QDEL is expected to report first-quarter fiscal 2021 results on May 6, 2021.\nThe ","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/QDEL\">Quidel Corporation</a></strong> QDEL is expected to report first-quarter fiscal 2021 results on May 6, 2021.</p>\n<p>The company delivered an earnings surprise of 9.6% in the last reported quarter. Further, its bottom line beat estimates in each of the trailing four quarters, the average being 30.9%.</p>\n<h3>Q1 Estimates</h3>\n<p>The Zacks Consensus Estimate for total revenues of $375.2 million implies growth of 114.9% from the prior-year quarter’s reported figure. Also, the consensus mark for earnings per share (EPS) is pegged at $4.87, indicating significant growth from the prior-year quarter’s reported figure.</p>\n<h3>Factors at Play</h3>\n<p>In the last reported quarter, Quidel’s Molecular Diagnostic Solutions delivered robust results. This momentum is likely to have continued in the to-be reported quarter as well. Further, higher sales of COVID-19 products are expected to have boosted growth in the to-be-reported quarter.</p>\n<p>The company is likely to have witnessed an uptick in rapid immunoassay revenues in the fiscal first quarter on higher sales derived from the Sofia platform. Progress of this platform is expected to have been aided by an increase in Sofia SARS Antigen and Sofia Combo ABC product sales.</p>\n<p>However, Quidel witnessed a decline in its specialized diagnostic solutions revenues in the last reported quarter. This downside was due to weak respiratory products in the company’s Cell Culture business, a trend that most likely continued in the fiscal first quarter too.</p>\n<p>Also, Quidel witnessed softness in its overall Influenza revenues in the fourth quarter of fiscal 2020 due to a very low prevalence of Influenza in the period, a trend that most likely persisted in the first quarter of fiscal 2021 as well.</p>\n<p>Nonetheless, overall molecular growth of the Lyra product category is expected to have contributed to the to-be-reported quarter’s top line, possibly led by an uptick in Solana SARS revenues.</p>\n<p>In the to-be reported quarter, the company’s Cardiometabolic Immunoassay business is expected to have been driven by strength in the Triage business and the Beckman BNP business.</p>\n<p>Advancement of the COVID-diagnostic product pipeline, especially with the Sofia Serology assay, is expected to have boosted the company’s performance in the fiscal first quarter. The FDA EUA approvals to market Solana SARS and QuickVue SARS Antigen is also expected to have driven growth in the to-be reported quarter.</p>\n<div>\n<h3>Quidel Corporation Price and EPS Surprise</h3>\n<img height=\"262\" src=\"https://s1.yimg.com/uu/api/res/1.2/Hu3H2e_X6msf7uWNu.NLmQ--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/zacks.com/0ec51457a5f7db18d95f58a0cbdfd4f8\" title=\"\" width=\"539\"/>\n<p>Quidel Corporation price-eps-surprise | Quidel Corporation Quote</p>\n</div>\n<p>Quidel has been evolving within its R&amp;D and instrument systems development teams for a while now. This, in turn, is expected to reflect on its results for the fiscal first quarter. Moreover, solid momentum of the Savanna cross-functional product development team might have enhanced the company’s to-be-reported quarter’s performance.</p>\n<p>In recent times, Sofia Q, formerly named Sniffles, which is the company’s next-generation Sofia platform, is steadily gaining traction. This is also likely to have bumped up the top line in the to-be-reported quarter.</p>\n<p>Additionally, the company is expected to have consistently benefited from newer products like Sofia Lyme, TriageTrue, High Sense, Troponin assay, Triage PLGF and the new Sofia GI suite in the quarter as well.</p>\n<h3>What Our Quantitative Model Suggests</h3>\n<p>Our proven model does not predict an earnings beat for Quidel this time around. The combination of a positive  Earnings ESP  and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that is not the case here as you will see.</p>\n<p><strong>Earnings ESP:</strong> Quidel has an Earnings ESP of -2.47%. You can uncover the best stocks to buy or sell before they're reported with our  Earnings ESP Filter.</p>\n<p><strong>Zacks Rank: </strong>Quidel carries a Zacks Rank #5 (Strong Sell).</p>\n<h3>Zacks Rank and Key Picks</h3>\n<p>Here are some medical stocks worth considering as these have the right combination of elements to beat on earnings this reporting cycle.</p>\n<p><strong>AmerisourceBergen </strong>ABC has an Earnings ESP of +0.23% and a Zacks Rank of 3, currently. You can see  <strong>the complete list of today’s Zacks #1 Rank stocks here.</strong></p>\n<p><strong>DENTSPLY SIRONA </strong>XRAY has an Earnings ESP of +11.36% and is a Zacks #2 Ranked stock, presently.</p>\n<p><strong>Cerner Corporation </strong>CERN has an Earnings ESP of +0.37% and a Zacks Rank of 3 at present.</p>\n<h3>More Stock News: This Is Bigger than the iPhone!</h3>\n<p>It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.</p>\n<p>Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.</p>\n<p><strong>Click here for the 4 trades &gt;&gt;</strong></p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\nDENTSPLY SIRONA Inc. (XRAY) : Free Stock Analysis Report\n<br/> \n<br/>\nCerner Corporation (CERN) : Free Stock Analysis Report\n<br/> \n<br/>\nAmerisourceBergen Corporation (ABC) : Free Stock Analysis Report\n<br/> \n<br/>\nQuidel Corporation (QDEL) : Free Stock Analysis Report\n<br/> \n<br/>\nTo read this article on Zacks.com click here.\n<br/> \n<br/>\nZacks Investment Research</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quidel (QDEL) to Report Q1 Earnings: What's in the Offing?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuidel (QDEL) to Report Q1 Earnings: What's in the Offing?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-05 00:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/quidel-qdel-report-q1-earnings-164704357.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Quidel Corporation QDEL is expected to report first-quarter fiscal 2021 results on May 6, 2021.\nThe company delivered an earnings surprise of 9.6% in the last reported quarter. Further, its bottom ...</p>\n\n<a href=\"https://finance.yahoo.com/news/quidel-qdel-report-q1-earnings-164704357.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/8qpOhG4H1El45cPbQkx24Q--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/fjS8E3eMtYWm5omrejEHog--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c7d7c00f4e1e615cc981c95227b4d9a3","relate_stocks":{"XRAY":"登士柏国际","CERN":"美国塞纳","QDEL":"窥得儿医药"},"source_url":"https://finance.yahoo.com/news/quidel-qdel-report-q1-earnings-164704357.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2133431805","content_text":"Quidel Corporation QDEL is expected to report first-quarter fiscal 2021 results on May 6, 2021.\nThe company delivered an earnings surprise of 9.6% in the last reported quarter. Further, its bottom line beat estimates in each of the trailing four quarters, the average being 30.9%.\nQ1 Estimates\nThe Zacks Consensus Estimate for total revenues of $375.2 million implies growth of 114.9% from the prior-year quarter’s reported figure. Also, the consensus mark for earnings per share (EPS) is pegged at $4.87, indicating significant growth from the prior-year quarter’s reported figure.\nFactors at Play\nIn the last reported quarter, Quidel’s Molecular Diagnostic Solutions delivered robust results. This momentum is likely to have continued in the to-be reported quarter as well. Further, higher sales of COVID-19 products are expected to have boosted growth in the to-be-reported quarter.\nThe company is likely to have witnessed an uptick in rapid immunoassay revenues in the fiscal first quarter on higher sales derived from the Sofia platform. Progress of this platform is expected to have been aided by an increase in Sofia SARS Antigen and Sofia Combo ABC product sales.\nHowever, Quidel witnessed a decline in its specialized diagnostic solutions revenues in the last reported quarter. This downside was due to weak respiratory products in the company’s Cell Culture business, a trend that most likely continued in the fiscal first quarter too.\nAlso, Quidel witnessed softness in its overall Influenza revenues in the fourth quarter of fiscal 2020 due to a very low prevalence of Influenza in the period, a trend that most likely persisted in the first quarter of fiscal 2021 as well.\nNonetheless, overall molecular growth of the Lyra product category is expected to have contributed to the to-be-reported quarter’s top line, possibly led by an uptick in Solana SARS revenues.\nIn the to-be reported quarter, the company’s Cardiometabolic Immunoassay business is expected to have been driven by strength in the Triage business and the Beckman BNP business.\nAdvancement of the COVID-diagnostic product pipeline, especially with the Sofia Serology assay, is expected to have boosted the company’s performance in the fiscal first quarter. The FDA EUA approvals to market Solana SARS and QuickVue SARS Antigen is also expected to have driven growth in the to-be reported quarter.\n\nQuidel Corporation Price and EPS Surprise\n\nQuidel Corporation price-eps-surprise | Quidel Corporation Quote\n\nQuidel has been evolving within its R&D and instrument systems development teams for a while now. This, in turn, is expected to reflect on its results for the fiscal first quarter. Moreover, solid momentum of the Savanna cross-functional product development team might have enhanced the company’s to-be-reported quarter’s performance.\nIn recent times, Sofia Q, formerly named Sniffles, which is the company’s next-generation Sofia platform, is steadily gaining traction. This is also likely to have bumped up the top line in the to-be-reported quarter.\nAdditionally, the company is expected to have consistently benefited from newer products like Sofia Lyme, TriageTrue, High Sense, Troponin assay, Triage PLGF and the new Sofia GI suite in the quarter as well.\nWhat Our Quantitative Model Suggests\nOur proven model does not predict an earnings beat for Quidel this time around. The combination of a positive  Earnings ESP  and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that is not the case here as you will see.\nEarnings ESP: Quidel has an Earnings ESP of -2.47%. You can uncover the best stocks to buy or sell before they're reported with our  Earnings ESP Filter.\nZacks Rank: Quidel carries a Zacks Rank #5 (Strong Sell).\nZacks Rank and Key Picks\nHere are some medical stocks worth considering as these have the right combination of elements to beat on earnings this reporting cycle.\nAmerisourceBergen ABC has an Earnings ESP of +0.23% and a Zacks Rank of 3, currently. You can see  the complete list of today’s Zacks #1 Rank stocks here.\nDENTSPLY SIRONA XRAY has an Earnings ESP of +11.36% and is a Zacks #2 Ranked stock, presently.\nCerner Corporation CERN has an Earnings ESP of +0.37% and a Zacks Rank of 3 at present.\nMore Stock News: This Is Bigger than the iPhone!\nIt could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.\nZacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.\nClick here for the 4 trades >>\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\nDENTSPLY SIRONA Inc. (XRAY) : Free Stock Analysis Report\n \n\nCerner Corporation (CERN) : Free Stock Analysis Report\n \n\nAmerisourceBergen Corporation (ABC) : Free Stock Analysis Report\n \n\nQuidel Corporation (QDEL) : Free Stock Analysis Report\n \n\nTo read this article on Zacks.com click here.\n \n\nZacks Investment Research","news_type":1},"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377489453,"gmtCreate":1619553237472,"gmtModify":1704725757085,"author":{"id":"3552211490267635","authorId":"3552211490267635","name":"MrK88088","avatar":"https://community-static.tradeup.com/news/177889ab348d52aa048bc5d523f30868","crmLevel":7,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3552211490267635","authorIdStr":"3552211490267635"},"themes":[],"htmlText":"Covid-19 will be around for quite a while. Testing still remains essential even after vaccination drive.&nbsp;","listText":"Covid-19 will be around for quite a while. Testing still remains essential even after vaccination drive.&nbsp;","text":"Covid-19 will be around for quite a while. Testing still remains essential even after vaccination drive.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/377489453","repostId":"2129649863","repostType":2,"repost":{"id":"2129649863","pubTimestamp":1619257764,"share":"https://ttm.financial/m/news/2129649863?lang=&edition=fundamental","pubTime":"2021-04-24 17:49","market":"us","language":"en","title":"Quidel Corporation (NASDAQ:QDEL) Analysts Just Cut Their EPS Forecasts Substantially","url":"https://stock-news.laohu8.com/highlight/detail?id=2129649863","media":"Simply Wall St.","summary":"Today is shaping up negative for Quidel Corporation (NASDAQ:QDEL) shareholders, with the analysts de","content":"<html><body><p>Today is shaping up negative for <strong><a href=\"https://laohu8.com/S/QDEL\">Quidel Corporation</a></strong> (NASDAQ:QDEL) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. Revenue and earnings per share (EPS) forecasts were both revised downwards, with the analysts seeing grey clouds on the horizon. </p>\n<p> Following the downgrade, the most recent consensus for Quidel from its five analysts is for revenues of US$2.1b in 2021 which, if met, would be a sizeable 25% increase on its sales over the past 12 months. Per-share earnings are expected to climb 18% to US$22.67. Previously, the analysts had been modelling revenues of US$2.4b and earnings per share (EPS) of US$27.78 in 2021. It looks like analyst sentiment has declined substantially, with a substantial drop in revenue estimates and a real cut to earnings per share numbers as well. </p>\n<p><span> View our latest analysis for Quidel </span></p>\n<figure>\n<img src=\"https://s1.yimg.com/uu/api/res/1.2/Sl6V1f9pQL.KT9w3CXlFjA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/simply_wall_st__316/c36b88f92a3800c1227dd64eb1fe668f\"/>\n<figcaption>\n  NasdaqGS:QDEL Earnings and Revenue Growth April 24th 2021\n </figcaption>\n</figure>\n<p> It'll come as no surprise then, to learn that the analysts have cut their price target 18% to US$185. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Quidel, with the most bullish analyst valuing it at US$326 and the most bearish at US$95.00 per share. So we wouldn't be assigning too much credibility to analyst price targets in this case, because there are clearly some widely differing views on what kind of performance this business can generate. As a result it might not be possible to derive much meaning from the consensus price target, which is after all just an average of this wide range of estimates. </p>\n<p> Of course, another way to look at these forecasts is to place them into context against the industry itself. It's pretty clear that there is an expectation that Quidel's revenue growth will slow down substantially, with revenues to the end of 2021 expected to display 25% growth on an annualised basis. This is compared to a historical growth rate of 39% over the past five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 9.3% annually. So it's pretty clear that, while Quidel's revenue growth is expected to slow, it's still expected to grow faster than the industry itself. </p>\n<h3>The Bottom Line </h3>\n<p> The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for Quidel. While analysts did downgrade their revenue estimates, these forecasts still imply revenues will perform better than the wider market. After such a stark change in sentiment from analysts, we'd understand if readers now felt a bit wary of Quidel. </p>\n<p> After a downgrade like this, it's pretty clear that previous forecasts were too optimistic. What's more, we've spotted several possible issues with Quidel's business, like concerns around earnings quality. For more information, you can click here to discover this and the 2 other risks we've identified. </p>\n<p> Another way to search for interesting companies that could be <strong> reaching an inflection point</strong> is to track whether management are buying or selling, with our <strong>free </strong>list of growing companies that insiders are buying. </p>\n<p><i>This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</i><br/><br/><strong>Have feedback on this article? Concerned about the content?</strong> <strong>Get in touch</strong><strong> with us directly.</strong><i> Alternatively, email editorial-team (at) simplywallst.com.</i></p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quidel Corporation (NASDAQ:QDEL) Analysts Just Cut Their EPS Forecasts Substantially</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuidel Corporation (NASDAQ:QDEL) Analysts Just Cut Their EPS Forecasts Substantially\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-24 17:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/quidel-corporation-nasdaq-qdel-analysts-094924497.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Today is shaping up negative for Quidel Corporation (NASDAQ:QDEL) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. Revenue and earnings per share (...</p>\n\n<a href=\"https://finance.yahoo.com/news/quidel-corporation-nasdaq-qdel-analysts-094924497.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/GRsO1lGjygtrxFOhNMtXmw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/S0lfvVFvT2zEUqilo.yhog--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2260c3158cb31199a7e2c221586ac549","relate_stocks":{"QDEL":"窥得儿医药"},"source_url":"https://finance.yahoo.com/news/quidel-corporation-nasdaq-qdel-analysts-094924497.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2129649863","content_text":"Today is shaping up negative for Quidel Corporation (NASDAQ:QDEL) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. Revenue and earnings per share (EPS) forecasts were both revised downwards, with the analysts seeing grey clouds on the horizon. \n Following the downgrade, the most recent consensus for Quidel from its five analysts is for revenues of US$2.1b in 2021 which, if met, would be a sizeable 25% increase on its sales over the past 12 months. Per-share earnings are expected to climb 18% to US$22.67. Previously, the analysts had been modelling revenues of US$2.4b and earnings per share (EPS) of US$27.78 in 2021. It looks like analyst sentiment has declined substantially, with a substantial drop in revenue estimates and a real cut to earnings per share numbers as well. \n View our latest analysis for Quidel \n\n\n\n  NasdaqGS:QDEL Earnings and Revenue Growth April 24th 2021\n \n\n It'll come as no surprise then, to learn that the analysts have cut their price target 18% to US$185. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Quidel, with the most bullish analyst valuing it at US$326 and the most bearish at US$95.00 per share. So we wouldn't be assigning too much credibility to analyst price targets in this case, because there are clearly some widely differing views on what kind of performance this business can generate. As a result it might not be possible to derive much meaning from the consensus price target, which is after all just an average of this wide range of estimates. \n Of course, another way to look at these forecasts is to place them into context against the industry itself. It's pretty clear that there is an expectation that Quidel's revenue growth will slow down substantially, with revenues to the end of 2021 expected to display 25% growth on an annualised basis. This is compared to a historical growth rate of 39% over the past five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 9.3% annually. So it's pretty clear that, while Quidel's revenue growth is expected to slow, it's still expected to grow faster than the industry itself. \nThe Bottom Line \n The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for Quidel. While analysts did downgrade their revenue estimates, these forecasts still imply revenues will perform better than the wider market. After such a stark change in sentiment from analysts, we'd understand if readers now felt a bit wary of Quidel. \n After a downgrade like this, it's pretty clear that previous forecasts were too optimistic. What's more, we've spotted several possible issues with Quidel's business, like concerns around earnings quality. For more information, you can click here to discover this and the 2 other risks we've identified. \n Another way to search for interesting companies that could be  reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying. \nThis article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.","news_type":1},"isVote":1,"tweetType":1,"viewCount":341,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}